Qkine appoints Indian distribution partner Biogenuix
Qkine is delighted to extended its global reach by agreeing a new sales distribution agreement with Biogenuix, an Indian distribution partner.
22
08, 2023
5
07, 2023
Qkine announces new partnership with Sartorius
Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.
3
05, 2023
Qkine officially opens new HQ and expanded manufacturing facility in Cambridge, UK
On Friday, 28th April 2023, Qkine officially opened its new HQ at Murdoch House, Cambridge, UK. We were delighted to be joined by Mayor Dr. Nik Johnson, the Mayor of Cambridge & Peterborough, alongside our team, customers, investors, and representatives from the Cambridge ecosystem.
2
05, 2023
New phase of growth as Qkine relocates into state-of-the-art facility
New phase of growth as Qkine relocates into state-of-the-art facility A Q&A with Dr. Andy Day, Head of Product Development and Manufacture at Qkine Qkine is entering the next phase of commercial growth, having secured the lease on 1 Murdoch House, based in Cambridge city centre, last year. [...]
3
03, 2023
Qkine is a Cofinitive #21toWatch Top21.2023 winner!
Qkine is excited to be a Top21.2023 winner in this year’s Cofinitive #21toWatch awards.
15
12, 2022
Qkine raises over £4M to scale manufacturing, R&D and commercial functions
Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M.
23
11, 2022
Qkine and 3D Bio-Tissues collaboration awarded €100,000 at EIT Food Venture Summit 2022
A collaboration between Qkine and 3D Bio-Tissues has been awarded one of four prestigious prizes at the 2022 EIT Food Venture Summit, held in Lisbon, Portugal. Prize money will be used to develop new solutions to reduce the cost of cultivated meat.
